Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by bogdanszon Mar 02, 2021 6:52pm
222 Views
Post# 32698608

AstraZeneca COVID-19 vaccine Not for Seniors !!!

AstraZeneca COVID-19 vaccine Not for Seniors !!!

Ontario won't administer AstraZeneca COVID-19 vaccine to seniors, final plan still in the works

TORONTO -- Ontario will limit the AstraZeneca vaccine to people under the age of 65 on the recommendations of the National Advisory Committee for Immunization (NACI), Ontario’s Health Minister confirmed, but the province is still finalizing the plan for who will be prioritized for that shot.

Christine Elliott also said the province is looking for guidance from the NACI on delaying the second dose of the COVID-19 vaccine by up to 16 weeks in an effort to dramatically expand the number of people receiving their initial inoculation, and suggested those recommendations will be the final key Ontario needs to unlock its plan.

“This could make a significant difference for Ontario in reducing hospitalizations and deaths,” Elliott told reporters at Queen’s Park. “As soon as we receive that [recommendation] we will be able to finalize the plan and get in front of you.”

The province is facing increasing pressure to reveal how it plans to vaccinate a broad segment of the population as it prepares to receive more than a hundred thousand doses of the AstraZeneca vaccine in the coming days.

The federal government announced 300,000 doses have been shipped from the Serum Institute of India -- putting Ontario’s per capita share at roughly 114,000 doses – all of which expire on Apr. 2.

“Right now, we're doing the calculation based on the AstraZeneca vaccine coming into the mix,” Elliott said. “This is something that we did after we got started with Pfizer and then we introduced Moderna. In the same way, we're building AstraZeneca into the plan as well.”

The quick expiration date raises questions about whether Ontario will be ready to administer the doses within the timeframe provided, given that the province’s portal to register patients for the vaccine will only be launched on Mar. 15.

Elliott told MPPs in the Ontario Legislature that the “big system” was soft-launched in select public health units on Monday because the government doesn’t want the portal to experience the type of crashes seen in Alberta and Quebec.

“We want it to be solid and to stand up to the pressure that we know is going to be coming because people are anxious to know when they’re going to be receiving the vaccine,” she said.

The NDP said the province is “unprepared” for the increased shipments of vaccines and said it was “obvious that they haven’t done their work.”

“We're literally days away from AstraZeneca arriving, why isn't the government being upfront, being clear, being transparent about what the plan is,” said NDP leader Andrea Horwath, who added that in the absence of a detailed plan, the government should have outlined the potential options that public health units could exercise.

While some of the government’s critics say the province should be cut some slack given the federal government’s ever-evolving vaccine rollout, they say it doesn’t excuse the province’s lack of clear direction.

“There's no question that this is not an easy endeavor, vaccinating 14 million people. That's why you need to plan, because then you can adapt quickly,” said Liberal MPP John Fraser.

<< Previous
Bullboard Posts
Next >>